Remissions induced in hereditary angioneurotic edema with an attenuated androgen (danazol): correlation between concentrations of C1-inhibitor and the forth and second components of complement.

Serum concentrations of antigenic and functional C1-INH increased in patients in whom remissions from attacks of HANE were induced with danazol. The levels of C4 were directly related to serum concentrations of C1-INH antigens up to a concentration of about half the C1-INH found in normal plasma; at this point, the C4 concentrations were in the normal range and no longer correlated well with C1-INH concentration. Serum C2 levels correlated less well with C1-INH concentration. In normal serum there was a poor correlation between C1-INH, C4, and C2 levels, suggesting that C1-INH is normally present in excess of the amount needed for normal C4 levels. The increments in serum C1-INH were related to the dose of danazol.

[1]  H. Saito,et al.  Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma. , 1977, The Journal of clinical investigation.

[2]  D. Alling,et al.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. , 1976, The New England journal of medicine.

[3]  R. O'rourke,et al.  Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction. , 1975, The Journal of clinical investigation.

[4]  D. Alling,et al.  A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement. , 1974, Journal of immunology.

[5]  F. Rosen,et al.  Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema. , 1971, The Journal of clinical investigation.

[6]  C. Forbes,et al.  Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator. , 1970, The Journal of laboratory and clinical medicine.

[7]  P. Harpel.  C[unk] inactivator inhibition by plasmin , 1970 .

[8]  I. Gigli,et al.  Fluid phase destruction of C2hu by C1hu. I. Its enhancement and inhibition by homologous and heterologous C4. , 1969 .

[9]  O. Ratnoff,et al.  THE INHIBITION OF PLASMIN, PLASMA KALLIKREIN, PLASMA PERMEABILITY FACTOR, AND THE C'1r SUBCOMPONENT OF THE FIRST COMPONENT OF COMPLEMENT BY SERUM C'1 ESTERASE INHIBITOR , 1969, The Journal of experimental medicine.

[10]  C. Laurell,et al.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. , 1966, Analytical biochemistry.

[11]  J. Heremans,et al.  Immunochemical quantitation of antigens by single radial immunodiffusion. , 1965, Immunochemistry.

[12]  F. Rosen,et al.  ACTION OF COMPLEMENT IN HEREDITARY ANGIONEUROTIC EDEMA: THE ROLE OF C'1-ESTERASE. , 1964, The Journal of clinical investigation.

[13]  I. Lepow,et al.  STUDIES ON HUMAN C'1-ESTERASE. II. FUNCTION OF PURIFIED C'1-ESTERASE IN THE HUMAN COMPLEMENT SYSTEM. , 1964, Journal of immunology.

[14]  I. Lepow,et al.  STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES. , 1964, Journal of immunology.

[15]  V. Donaldson.  Studies on the activation of a serum esterase with ether and its relationship to C'l-esterase. , 1961, The Journal of clinical investigation.

[16]  I. Lepow,et al.  Assay and Properties of Serum Inhibitor of C'1-Esterase∗ , 1959, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[17]  O. Ratnoff,et al.  SOME PROPERTIES OF AN ESTERASE DERIVED FROM PREPARATIONS OF THE FIRST COMPONENT OF COMPLEMENT , 1957, The Journal of experimental medicine.